156 related articles for article (PubMed ID: 38049415)
1. Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma.
Yin DP; Zhang H; Teng H; Zhang D; Chen P; Xie L; Liu JS
Cell Death Dis; 2023 Dec; 14(12):792. PubMed ID: 38049415
[TBL] [Abstract][Full Text] [Related]
2. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma.
Yin DP; Zheng YF; Sun P; Yao MY; Xie LX; Dou XW; Tian Y; Liu JS
Cell Death Dis; 2022 Mar; 13(3):210. PubMed ID: 35246508
[TBL] [Abstract][Full Text] [Related]
3. LncRNA PINK1-AS promotes Gαi1-driven gastric cancer tumorigenesis by sponging microRNA-200a.
Lv Y; Wang Y; Song Y; Wang SS; Cheng KW; Zhang ZQ; Yao J; Zhou LN; Ling ZY; Cao C
Oncogene; 2021 Jun; 40(22):3826-3844. PubMed ID: 33958720
[TBL] [Abstract][Full Text] [Related]
4. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
[TBL] [Abstract][Full Text] [Related]
5. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth.
Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J
Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426
[TBL] [Abstract][Full Text] [Related]
6. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.
Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C
Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803
[TBL] [Abstract][Full Text] [Related]
7. microRNA-200a downregulation in human glioma leads to Gαi1 over-expression, Akt activation, and cell proliferation.
Liu YY; Chen MB; Cheng L; Zhang ZQ; Yu ZQ; Jiang Q; Chen G; Cao C
Oncogene; 2018 May; 37(21):2890-2902. PubMed ID: 29520106
[TBL] [Abstract][Full Text] [Related]
8. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer.
Peng SQ; Zhu XR; Zhao MZ; Zhang YF; Wang AR; Chen MB; Ye ZY
Cell Death Dis; 2023 Feb; 14(2):157. PubMed ID: 36828810
[TBL] [Abstract][Full Text] [Related]
9. Gαi1/3 mediate Netrin-1-CD146-activated signaling and angiogenesis.
Li Y; Chai JL; Shi X; Feng Y; Li JJ; Zhou LN; Cao C; Li KR
Theranostics; 2023; 13(7):2319-2336. PubMed ID: 37153740
[TBL] [Abstract][Full Text] [Related]
10. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
Wang MH; Sun R; Zhou XM; Zhang MY; Lu JB; Yang Y; Zeng LS; Yang XZ; Shi L; Xiao RW; Wang HY; Mai SJ
Cell Death Dis; 2018 Jan; 9(1):2. PubMed ID: 29305578
[TBL] [Abstract][Full Text] [Related]
11. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
Xie Z; Li W; Ai J; Xie J; Zhang X
J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661
[TBL] [Abstract][Full Text] [Related]
12. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of EGFR/PI3K/AKT/mTOR pathway.
Wang J; Shang Y; Wang Y; Li Y; Wang L; Huang S; Lyu X
Histol Histopathol; 2024 May; 39(5):647-657. PubMed ID: 37971211
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
[TBL] [Abstract][Full Text] [Related]
15. SCF/c-Kit-activated signaling and angiogenesis require Gαi1 and Gαi3.
Shan HJ; Jiang K; Zhao MZ; Deng WJ; Cao WH; Li JJ; Li KR; She C; Luo WF; Yao J; Zhou XZ; Zhang D; Cao C
Int J Biol Sci; 2023; 19(6):1910-1924. PubMed ID: 37063428
[TBL] [Abstract][Full Text] [Related]
16. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
[TBL] [Abstract][Full Text] [Related]
17. Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma.
Su C; Li M; Yang Y; Wang Z; Wang Q; Wang W; Ma X; Jie R; Chen H; Li X; Lu J
Anticancer Agents Med Chem; 2023; 23(17):1944-1957. PubMed ID: 37497684
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals.
Zhang W; Zhang Y; Xi S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3043-3052. PubMed ID: 31334669
[TBL] [Abstract][Full Text] [Related]
19. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
20. SLC5A3 is important for cervical cancer cell growth.
Li L; Shen FR; Cheng Q; Sun J; Li H; Sun HT; Cai X; Chen M; Yang B; Wang L; Xu L
Int J Biol Sci; 2023; 19(9):2787-2802. PubMed ID: 37324953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]